Strong India ops, Huron export delays & margin compression mask solid order book
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Maintained 25-30% FY27 guidance despite Q1 landing at 24% YoY growth, lowest end of range. Margin guide (25%) not hit (21.4% delivered). Huron accounting change explained but normalized timeline unclear.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Standalone India business delivers solid 37% growth with 27% margins, but Huron's ₹35 Cr unrecognized revenue and geopolitical export licensing delays crimp consolidated profit 20% YoY despite 24% revenue growth. Margin guidance (25%) missed at 21.4%, signalling absorption of new-facility capex and staffing costs not fully disclosed. Strong ₹4,848 Cr order book and Sep 2026 capacity expansion offer medium-term upside if Huron normalizes and execution holds; near-term Huron headwinds and margin pressure warrant caution.
₹508.5 Cr
Revenue · +24% YoY₹57.1 Cr
Reported PAT · −20% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Consolidated revenue INR508.5 Cr at 24% YoY growth
METDelivered exactly ₹508.5 Cr, 24% YoY confirmed
EBITDA margin 25% guidance sustainable
OVERSTATEDQ1 reported margin 21.4%, adjusted 23.4% – 150-360 bps miss vs prior guidance
PAT INR57 Cr with 11.2% margin
METDelivered exactly ₹57.1 Cr, 11.2% margin confirmed – but down 20% YoY
Standalone Q1 revenue ₹509 Cr, 37% YoY growth, 27% EBITDA margin
MET₹509 Cr, 37% growth, 27.2% reported / 28.4% adjusted margin verified. Very strong.
Huron accounting change is temporary, underlying business intact
MISS₹35 Cr revenue miss in Q1 + ₹20-22 Cr margin impact tied to export licensing delays (geopolitical). Persistent risk.
Order book ₹4,848 Cr provides good revenue visibility
METAt ₹508.5 Cr Q1 run rate, OB = 9.5x quarterly sales – strong, above prior ₹4,585 Cr guidance.
Earnings quality
What changed since the last call
Huron accounting POCM → delivery basis
DowngradeFY26 used percentage completion (smoothed revenue), now requires end-user certification before revenue recognition. Q1 FY26 ₹70 Cr → Q1 FY27 ₹35 Cr. Creates lumpiness and near-term optics hit.
Export licensing timelines lengthened
DowngradeGeopolitical (US-China, EU-Turkey tensions) forcing EU defense ministry to request additional end-user data. Q1 revealed 7-8 machines in customs hold. Was not on previous call radar.
Capacity expansion on track
NeutralStill targeting Sep 2026 (99% on time per MD). Foundry 1 month delayed (Oct). No capex overrun (tracking ₹450 Cr budget). Positive vs typical infra execution risk.
Margin guidance maintained despite near-term miss
NeutralReaffirmed 25% EBITDA guide for FY27 and FY28. Q1 delivered 21.4% (adjusted 23.4%), attributed to Huron drag + facility ramp costs. Confidence in H2 recovery implicit but unproven.
Order book raised to ₹4,848 Cr
Upgradevs prior ₹4,585 Cr. Aerospace/defense orders (38% of OB) up; EMS waiting for PLI clarity before converting to orders. Visibility strong into H2.
The Q&A
Analysts pressed hard on three fronts: (1) margin compression – why is PAT down 20% if revenue up 24%? Management blamed Huron revenue miss + capex interest, but didn't itemize staffing/facility ramp costs. Analyst Nayak suggested ₹20-25 Cr of absorbed costs; MD confirmed ₹20-22 Cr from Huron alone but didn't dispute broader estimate. (2) Huron accounting – why switch methods mid-stream? MD defended auditor conservatism due to export license uncertainty; several analysts challenged whether this was temporary or structural (no clear answer). (3) Competitive threat – BFW capacity expansion in India; MD deflected, saying competition is 'part of life.' Overall, MD held line on guidance but tone was cautious, defensive on internal systems (Kamlesh asked about auditor change / HR quality; MD deflected).
Capex, facility ramp — Harshit Patel, Equirus
Answered₹200-225 Cr expansion capex in FY27 + ₹150 Cr balance + maintenance = ~₹300-350 Cr total. 80% of machine shop done, sheet metal by end of week, paint this week, assembly ready, foundry delayed to Oct. 99% on schedule.
Working capital, OCF — Harshit Patel, Equirus
PartialWC in inventory stage will improve drastically once new facility operational post-Sep. Expecting to be positively surprised on OCF.
Gross margin, staff costs, interest — Ravindranath Nayak, Nirmal Bang
PartialStandalone margin 27%+ on track. Huron revenue ₹35 Cr miss this Q vs ₹70 Cr YoY = ₹35 Cr revenue shortfall, which carries ₹20-22 Cr margin. Consolidated drag is 100% Huron. Interest booked as cost, not capitalized, because facility already partially in use. Margin will restate once Huron revenue books.
Export licenses, revenue recognition — Saif Sohrab Gujar, ICICI Pru AMC
AnsweredNot one machine, but all export licenses taking longer. Waiting mode until license received, then certainty to dispatch. Conservative method adopted by auditors and local authorities. Management met authorities 2-3 times; they are positive and will clear soon.
Accounting change, POCM vs delivery — Bajrang Bafna, Sunidhi Securities
AnsweredAbsolutely correct. Revenue should have been ₹35 Cr higher, margin ₹22 Cr higher under old method. Lumpiness is new reality; must look at full-year performance, not Q-to-Q.
EMS market demand, lumpiness impact — Aniket Jain, Anand Rathi
PartialEMS busy, customers waiting for PLI clarity; 200+ employees engaged. Not yet orders. Lumpiness is business reality for large machines; need to view on yearly basis. Machine tool co, not Q-to-Q watcher.
Realization per machine — Arafat, Dolat Capital
AnsweredQ1 FY26 avg ₹34.41 Lakh. Q1 FY27 ₹34.56 Lakh – almost similar. With entry-level and mid-level machines ramping, will stay in this range 1-2 years.
Capacity utilization, replacement demand — Shwetha, ithoughtPMS
AnsweredFY26 end 90% on 5,550 machines built. Q1 86% because base now 6K machines (new capacity target). Today almost 90% utilization. Yes, replacement demand high – Rajkot alone booked 250 machines in July. People from 2000-2005 replacing with new tech.
Huron subsidiary loss, bifurcation — Prerak Gandhi, Sowilo Investment
Answered100% from revenue miss. Last Q1 FY26 ₹7M EUR turnover. This Q1 FY26.5M manufactured but only ₹3M billed (export delays). ₹35 Cr unrecognized revenue, all costs booked = ₹30 Cr gap.
Huron end-user certificates, geopolitical — Prerak Gandhi, Sowilo Investment
AnsweredInvestigation and end-user certs are different. EUC needed historically, now taking longer due to geopolitical (defense ministry multi-level checks). Siemens controller licensing via Germany adds layer. Chinese and Turkish customers particularly delayed. No near-term normalization timeline.
Huron FY27 guidance, EBITDA margin — Abhishek Jain, KRIIS PMS
AnsweredHuron FY27 revenue ₹300-325 Cr (at 8-10% EBITDA margin). Full capacity ₹750 Cr (expanded Nov-Dec last year). Will be EBITDA positive, implied PAT positive via corporate allocation.
CNC controller development, PLI capex — Abhishek Jain, KRIIS PMS
AnsweredHMI ready. Commercialization in next 2 years. PLI applied, eligible; 25% capex subsidy from center + equal from state = ~50% total. Plans ready, awaiting PLI clearance.
Internal systems, auditor, HR processes — Kamlesh, Lotus Asset Managers
DodgedContinuous improvement is ongoing. ISO 9000 certified. If processes not in place, world's largest customers won't qualify us. Suggestion noted, will consider. Performance comes from people quality.
POCM history, prior year method — Kamlesh, Lotus Asset Managers
AnsweredPOCM in Huron since 20 years. Only one condition added now – uncertainty from end-user cert delays. Method modified, not closed. Will add back POCM once EUC received.
Order intake QoQ, execution gap — Sanjay, Bastion Research
AnsweredAlready have stretch OB. Dispatching ₹510 Cr, OB ₹600 Cr. Customers waiting for execution proof (higher delivery speed) before placing more. Once capability proven, orders will flow.
Sequential margin drop 320 bps, QoQ comp — Sanjay, Bastion Research
PartialStandalone margin 27.5% intact. Huron ₹35 Cr revenue miss = ₹20+ Cr margin miss. Sequential compression is primarily Huron accounting change, not operational cost creep.
Large machine import, NX product, market — Ravindranath Nayak, Nirmal Bang
AnsweredLarge machines 5m+ mainly from Taiwan, Korea. India imports 300+ machines/year in this category. Value ₹3-5 Cr per machine. Railway expanding, some orders in Q1. 5-axis simultaneous but not in multi-axis.
Export license scope (India vs Huron sales) — Aniket Jain, Anand Rathi
AnsweredYes, every machine tool company if controller is controlled (Siemens FANUC). Siemens obtains license on our behalf. Huron is in Europe, so they take certificate there. Germany/Italy/Spain within EU don't need export license.
Replacement demand cycle, ASP uplift — Jay Shah, Genuity Capital
AnsweredAbsolutely. India manufacturing maturing, moving to high-value chain. Chinese/Taiwan business coming via 'China Plus One.' Tier 1/2 suppliers upgrading machinery for Airbus/Dassault programs. Precision increasing. Yes, ASP will rise over time.
Huron capacity, machine count for revenue — Jay Shah, Genuity Capital
Answered240 machines is model-mix capacity. Orders are large (>EUR1M per machine). Capacity value is EUR75M = ₹750 Cr. EBITDA 8-10% positive, PAT positive yes (capacity expanded Nov-Dec last year).
Deferred Huron revenue, timing — Depesh Kashyap, Invesco MF
Answered7-8 machines, multiple orders. Once licenses clear, expect all to clear together in batch. Already applying for license from day 1 on new orders (vs prior 2-3 months before completion).
Debt level, OCF generation — Depesh Kashyap, Invesco MF
AnsweredMar to Aug debt level almost same. Capex ₹200-225 Cr in FY27, debt discipline (1:2 EBITDA limit). Expecting ~50% of EBITDA as OCF conversion.
Investigation at Huron, impairment risk — Saurabh Vyas, Systematix
AnsweredNo, not at all. Investigation is separate from accounting treatment.
Guidance
FY27 revenue growth 25-30% (consolidated basis)
MediumQ1 landed at 24% (bottom of range). Standalone 37%, Huron dragging at -50% due to export delays. H2 ramp from Sep facility + license clearance expected to drive 25-30% full year.
Huron FY27 revenue ₹300-325 Cr
MediumQ1 ₹35 Cr (accounting change basis). Would be ~₹70 Cr annualized under old POCM; now bumpy. Export licenses for ~₹100 Cr backlog pending; if cleared Q2/Q3, can achieve ₹300-325 Cr range.
FY27 full-year order intake ₹2,500-3,000 Cr
HighQ1 ₹600 Cr. Order book ₹4,848 Cr provides visibility. Customers holding back until execution capability proven, then pent-up demand expected.
EBITDA margin 25% (standalone 25%+ always guided, consolidated 25% for FY27-FY28)
LowQ1 consolidated reported 21.4%, adjusted 23.4%. Miss of 360 bps (reported) / 150 bps (adjusted). Attributable to Huron drag + interest cost from capex (not capitalized). Requires execution.
Huron EBITDA margin 8-10%
MediumMuch lower than India 25%+ due to scale (240 machines/yr) and competitive intensity in defense aerospace globally. Margin accretive once revenue scales above ₹500 Cr (not near-term).
FY27 capex ₹200-250 Cr (expansion), balance of ₹150 Cr + maintenance capex
HighTotal capacity expansion ₹450 Cr targeting Sep 2026 completion. 99% on track per MD. New facility will add 10,000 machines/year, expand foundry, sheet metal, paint, assembly in-house.
Risks the call surfaced
Geopolitical export delays
HighHuron machines (5-axis, precision) subject to EU/German defense ministry end-user certification for China, Turkey, Middle East customers. Approval timelines extended from weeks to months (2026 geopolitical tensions). 7-8 machines (~₹100 Cr cumulative) stuck in customs hold.
Accounting volatility (Huron POCM→delivery)
HighSwitched from percentage completion method (smoothed revenue, large deals over 6-12 months) to delivery-basis (lumpiness). Auditor driven by export license uncertainty. Creates ₹30-100 Cr revenue swings QoQ, masking underlying operational trends.
Margin compression (near-term)
MediumConsolidated OPM 21.4% vs 25% guidance (360 bps miss). PAT -20% YoY despite +24% revenue (negative operating leverage). Driven by Huron revenue miss (₹20-22 Cr margin impact), interest cost up (capex financing), staff cost up (expansion hiring). New facility ramp-up capex absorption not fully itemized.
New facility ramp-up execution
MediumSep 2026 launch of 10,000 machine/year facility (67% increase over current 6K base). Foundry delayed to Oct. Machine shop, sheet metal, paint, assembly on track. Staffing, inventory buildup, absorption of depreciation over next 12 months pose margin headwind. New products (NX machine) unproven in market.
ASP & mix pressure
LowEntry-level machine sales up 36% (from 994 to 1,349), mid-range down 68% (104 to 33), high-end flat (19 to 24). Entry-level is lower-margin. ASP ₹34.56 Lakh/machine flat YoY. As production capacity scales post-Sep, entry-level machines may dominate, capping margin upside despite volume growth.
Internal systems & compliance
MediumAnalyst raised concerns about HR, CFO systems, and audit quality (media complaints circulating). MD deflected, citing ISO 9000 certification and customer requirements. No commitment to auditor change or detailed remediation plan. Reputational risk if media narratives persist.
Management
Score 6/10. MD transparent on Huron accounting change and export delays, but defensive on internal systems (HR/CFO/audit). Provided detailed capex and facility ramp updates. However, margin compression narrative was deflected (Huron blamed, but broader cost drivers not itemized). Analyst pressure on interest costs and staffing absorptions not fully answered. Capacity expansion 99% on track (Sep 2026), order book growth (₹4,585→₹4,848 Cr), standalone India 37% YoY growth achieved. But PAT -20% YoY despite 24% revenue growth is a miss vs historical execution. Huron performance deteriorated (-50% revenue, ₹30 Cr loss, export delays not pre-disclosed). Prior guidance (25-30% growth, 25% margin) not being beaten; Q1 at bottom/below range.
1 · Sep 2026
New facility (10,000 machine capacity) goes live; backward integration (foundry, sheet metal, paint, assembly) operationalized. Foundry delayed to Oct.
2 · Q2 FY27 onwards
Huron export licenses expected to clear in batch; 7-8 held machines to dispatch, creating revenue lumps. Management targeting improved Q2 dispatch.
3 · H2 FY27
New facility ramp drives 25-30% revenue growth as capacity fills. Order book (₹4,848 Cr) visibility into H2 strong.
Strong ₹4,848 Cr order book and Sep 2026 capacity expansion offer medium-term upside if Huron normalizes and execution holds; near-term Huron headwinds and margin pressure warrant caution.
Standalone 37% growth masked by Huron's ₹100-crore export gridlock
Revenue grew 24% to ₹508.5 crore, but consolidated profit collapsed 20% to ₹57.1 crore — driven by Huron's unrecognized ₹100-crore revenue backlog from export licensing delays and an accounting method switch mid-year, plus margin compression that management's disclosed ₹20–22 crore Huron impact doesn't fully explain.
₹509 Cr
+37% YoY, core engine intact
₹508.5 Cr
+24% YoY, Huron drag -13pp
₹88 Cr
+21% YoY, 17.3% margin
₹57.1 Cr
-20% YoY, 11.2% margin
The headline is deceptive. Revenue growth looks solid at 24%, but consolidated profit actually fell 20% — the opposite of what you'd expect from expanding sales. This gap tells the whole story of Q1.
Where the 20% profit collapse came from
Standalone India is doing exactly what management promised: ₹509 crore revenue (+37% YoY), 27.2% EBITDA margin, PAT up 21% to ₹88 crore. But consolidated India-plus-Huron tells a different story. Huron, the French CNC subsidiary, generated only ₹35 crore in Q1 vs ₹70 crore a year ago. That ₹35 crore revenue miss carried a ₹20–22 crore margin hit. The reason: export licensing delays and an accounting method change mid-year.
The Huron revenue hold: ₹100 crore stuck in geopolitical limbo
Huron used percentage-of-completion accounting to recognize revenue on large defence and aerospace machines as they're built over 6–12 months. But in Q4 FY26, auditors demanded a shift: no revenue until end-user certificates arrive. Why? Export licenses from the EU and German defence ministry are taking far longer than historical norms — 7–8 machines (~₹35 crore per quarter) are stuck awaiting certifications for Chinese and Turkish customers, caught in US-China geopolitical tensions and EU defence scrutiny. The method switch meant Q4 FY26 saw ₹67 crore revenue reversed, and Q1 FY27 just saw ₹35 crore deferred. Total unrecognized backlog: ~₹100 crore. When licenses clear, that revenue will lump into one quarter — optics victory, but no new cash gain.
But there's more: the margin compression gap
If Huron's ₹20–22 crore margin hit fully explained the consolidated profit slide, that would be the end of the story. But it doesn't. Consolidated EBITDA was 21.4%, vs. a 25% guidance — a 360 basis-point miss (or 150 bps adjusted for forex). Management blamed Huron entirely, but the math doesn't hold: PAT fell 20% YoY despite 24% revenue growth. That's negative operating leverage of 400+ basis points. In other words, costs are rising faster than revenue — and not just from Huron. Interest expense is up (capex financing ₹450 crore for the new facility), staffing costs are up, and facility ramp absorption hasn't been itemized. Analyst push-back on the call hinted at this; the CFO didn't challenge the broader cost narrative, only reaffirmed Huron as the primary culprit.
Consolidated revenue ₹508.5 Cr at 24% YoY growth
SupportedDelivered exactly ₹508.5 Cr, 24% YoY confirmed
EBITDA margin 25% guidance is sustainable
OverstatedQ1 reported 21.4%, adjusted 23.4% — miss of 360 bps (reported) / 150 bps (adjusted)
Huron accounting change is temporary, underlying business intact
Contradicted₹100 Cr cumulative unrecognized revenue; export delays are geopolitical (EU defence ministry, China/Turkey tensions), no near-term resolution timeline
Order book ₹4,848 Cr provides strong revenue visibility
SupportedAt ₹508.5 Cr Q1 run rate, OB = 9.5x quarterly sales, up from prior ₹4,585 Cr guidance
Standalone India is growing as expected
SupportedStandalone ₹509 Cr, +37% YoY at 27.2% EBITDA margin — very strong, tracking guidance
What changed on this call
Huron export delays went public. Prior calls made no mention of licensing bottlenecks; this call revealed 7–8 machines (~₹35 crore per quarter) in customs hold awaiting EU/German defence ministry certifications. The accounting method switched from POCM to delivery-basis mid-year — auditor-driven conservatism re. geopolitical risk. Order book raised to ₹4,848 crore from ₹4,585 crore guidance (+₹263 crore, +5.7%), but this came with no upgrade to revenue or margin guidance. Capacity expansion remains on track (99%) for Sep 2026, expanding from 6,000 to 10,000 machines/year. But the new facility's ramp-up costs — depreciation, staffing, interest on ₹450 crore capex — are being absorbed as a drag on margins, not detailed as discrete line items.
The market's read — caution amid the pop
The stock popped on the result announcement (day 1 +2.17%, held to day 5 +5.75%). That's a tentative thumbs-up, not a conviction buy. More telling: the stock is -21.69% from its all-time high of ₹1,055.9, now at ₹826.9 — near its 50-day and 200-day moving averages, suggesting consolidation. FII ownership has been trimming: down 2.65 percentage points QoQ to just 6.29%. That's smart-money skepticism on the margin story. RSI is 54.7 (neutral), not overbought. The market accepted the result but is not excited — it's waiting for proof that Sep's facility ramp and Huron's license batch clearance will restore margin to guidance.
Standalone India ₹509 Cr at 37% YoY growth, 27.2% margin
Order book ₹4,848 Cr (record), 9.5x quarterly sales
New facility (10K capacity) Sep 2026, 99% on track, 67% increase
PLI tailwinds (semiconductors), import substitution, NX machine for rail
Consolidated PAT fell 20% YoY despite 24% revenue growth
EBITDA margin 21.4% vs 25% guidance; 360 bps miss
Huron ₹100 Cr unrecognized revenue, export delays (geopolitical, sticky)
Accounting volatility (POCM→delivery), ₹30–100 Cr Q-to-Q swings
Guidance maintained, not upgraded, despite record order book
Interest cost up (capex ₹450 Cr), staff cost up, no itemization
FII trimming 2.65pp QoQ; stock 21% off ATH
Internal systems concerns (HR, CFO, audit) unaddressed
Huron export license delays (geopolitical, EU defence ministry)
High7–8 machines (~₹35 Cr/quarter) stuck awaiting certifications. No timeline for resolution. If tensions persist, ₹100 Cr backlog becomes structural headwind. Margin pressure extends into H2.
Margin compression not fully reconciled (360 bps miss)
HighManagement blamed ₹20–22 Cr Huron impact, but PAT -20% YoY vs +24% revenue suggests broader cost absorption (interest, staff, facility ramp). Credibility gap weakens confidence in guidance.
PAT fell 20% YoY despite 24% revenue (negative operating leverage)
MediumImplies structural cost absorption beyond Huron. If persists into H2, suggests facility ramp absorption is heavier than expected or mix shift to lower-margin entry-level machines is more pronounced.
Huron accounting volatility (POCM→delivery, ₹30–100 Cr Q-to-Q)
MediumEarnings become unreadable Q-to-Q. Lumpiness in large machine orders is inherent, but method switch amplifies optics noise. Investors struggle to parse underlying operational trends.
New facility ramp-up execution (Sep 2026 launch, 10K capacity)
MediumFoundry delayed to Oct (1 month slip). Depreciation, staffing, inventory buildup, and absorption of idle capacity over 12 months pose margin drag into FY28.
Internal systems & compliance (HR, CFO, audit concerns)
LowMedia narrative on governance quality persists. MD deflected, cited ISO 9000. No commitment to auditor change or remediation. Reputational risk if story escalates.
1 · Huron export license batch clearance (Q2–Q3 FY27)
If 7–8 machines clear in batch, watch for lump quarter revenue (+₹35–70 Cr) and margin recovery (+₹20–22 Cr). Management is targeting Q2 dispatch. Timeline is critical to validate the 'temporary' narrative.
2 · Sep 2026 new facility operational ramp
Machine shop live, foundry by Oct. Watch for depreciation absorption hitting EBITDA margins and capacity utilization rates over Oct–Dec. If utilization reaches 80%+ within 3 months of launch, ramp is on track.
3 · Q2 FY27 consolidated EBITDA margin (ex-Huron accounting lump)
The number that determines if guidance is credible. If Q2 approaches 25% (ex-Huron), the margin miss is Huron-driven and transient. If Q2 stays 21–23%, there's a structural issue. This is the canary.
Jyoti's standalone India business is firing — 37% growth, 27% margins, record order book. But consolidated profit fell 20% YoY, driven by Huron's export licensing gridlock and a margin compression that management's disclosed drivers don't fully reconcile. The debate isn't whether India is strong; it's whether Huron's ₹100-crore unrecognized revenue backlog (and the cost absorption beneath the margin miss) is temporary accounting noise or a structural geopolitical headwind.
Management reaffirmed 25–30% FY27 revenue growth and 25% EBITDA margin guidance. But Q1 delivered 24% revenue growth and 21.4% EBITDA — the bottom and below the stated range. The market's post-result pop (+5.75% by day 5) held, but skepticism is evident: FII have trimmed 2.65pp, and the stock sits 21% below its all-time high. Until Sep's facility launch operationalizes and Huron's export license batch clears (likely Q2–Q3), execution remains opaque.
The number to track from here: consolidated EBITDA margin in Q2 FY27. If it approaches 25% ex-Huron accounting noise, the thesis is intact — buy the facility ramp and license recovery. If it stays 21–23%, there's a structural cost absorption problem that guidance doesn't acknowledge. That's the signal that separates steady execution from a step-down.
Jyoti CNC Q1FY27: consolidated PAT falls 20% YoY as French subsidiary losses hit margins
PAT -19.99% YoY · revenue +23.97% · margins compressing
₹508.47 Cr
+23.97% YoY
₹57.14 Cr
-19.99% YoY
11.15%
-5.4pp YoY
₹2.51
Jyoti CNC's Q1FY27 (quarter ended June 30, 2026) consolidated print was mixed: revenue rose 23.97% YoY to ₹508.47 Cr (₹410.17 Cr a year ago) but PAT fell 19.99% YoY to ₹57.14 Cr (₹71.42 Cr) — profit declining even as the top line grew. Sequentially both metrics eased from a stronger Q4FY26 (revenue -15.13% QoQ from ₹599.16 Cr, PAT -36.92% QoQ from ₹90.57 Cr), consistent with a seasonally softer Q1 for an order-book-driven capital-goods business. Consolidated EPS was ₹2.51 versus ₹3.14 a year ago. No reliable street estimates specific to this quarter's print could be sourced, so the actual cannot be benchmarked against consensus (vsStreet: unknown).
Q1 FY-2027 vs prior quarters
The YoY profit decline sits entirely on the margin line, not on any exceptional item — both periods show nil exceptional/extraordinary items. Consolidated NPM compressed to 11.24% from 16.58% a year ago, and OPM (EBITDA margin) fell to 21.40% from 24.43%, both now below management's own guided 25-27% EBITDA margin band for FY27/FY28 laid out on the Q3FY26 concall. The compression traces to the group's overseas operations: per the auditor's review note, subsidiaries and step-down subsidiaries (including the French Huron entities) posted a combined net loss of ₹30.07 Cr on just ₹32.21 Cr of revenue this quarter. That overseas drag is the entire story behind the standalone-vs-consolidated gap — standalone (parent-only) PAT was ₹87.47 Cr, up 21.28% YoY, with EPS of ₹3.85, more than 50% higher than the consolidated EPS.
The stock went into the print at ₹797.15, up 3.7% over the past month of trading.
Management guides for robust 25-30% revenue growth in both FY'27 and FY'28, supported by a strong INR 4,585 crore order book and a major capacity expansion in India set to triple capacity by September 2026. The company is confident in maintaining stable EBITDA margins within the 25-27% range over the next two years. St
— This quarter: missed
The overseas drag is not new: step-down subsidiary Huron Graffenstaden SAS (France) remains under an ongoing French judicial investigation into alleged dual-use export-control violations, with interim seizure of €3.02 million in funds and two Jyoti SAS-owned residential properties, and restrictions on the entity's Director General — unchanged from prior disclosures. Standalone financials also carry a management note that no impairment has been taken on the investment in this loss-making subsidiary chain, on the view that recovery is likely and the investment remains strategic — auditors did not qualify this but it is a judgment call worth tracking. On revenue, consolidated growth of 23.97% YoY trails the lower end of management's guided 25-30% FY27 band (given alongside confidence in tripling India capacity by September 2026); the quarter is a narrow miss on revenue guidance and a more pronounced miss on the margin guidance.
W1
India capacity expansion targeted to triple by September 2026 — watch for ramp confirmation and its effect on revenue growth toward the guided 25-30% FY27 band
W2
EBITDA margin trajectory back toward management's guided 25-27% range from this quarter's 21.40% OPM
W3
Status/resolution of the French judicial investigation into Huron Graffenstaden SAS and its ~₹30 Cr quarterly drag on consolidated group profit
Consolidated PAT diverges sharply from standalone (-20.0% YoY vs +21.3% YoY) due to a ~₹30 Cr quarterly loss at overseas step-down subsidiaries incl. Huron Graffenstaden SAS (France, under judicial investigation); no exceptional items in either period; OPM computed as (PBT+finance costs+depreciation-other income)/revenue to match prior-quarter DB methodology.